Evidence map›Paper›PMID 38625255›Full record

ArticleEvolving systems2023

AMTLDC: a new adversarial multi-source transfer learning framework to diagnosis of COVID-19.

Hadi Alhares, Jafar Tanha, Mohammad Ali Balafar

Abstract read
In one paragraph

Article in Evolving systems, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Self-supervised Semantic Segmentation: Consistency over Transformation.... IEEE International Conference on Computer Vision workshops. IEEE International Conference on Computer Vision · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hadi AlharesDepartment of Computer Engineering, Faculty of Electrical and Computer Engineering, University of Tabriz, 29th Bahman Blvd, Tabriz, 5166616471 Iran.
Jafar TanhaDepartment of Computer Engineering, Faculty of Electrical and Computer Engineering, University of Tabriz, 29th Bahman Blvd, Tabriz, 5166616471 Iran.ORCID 0000-0002-0779-6027
Mohammad Ali BalafarDepartment of Computer Engineering, Faculty of Electrical and Computer Engineering, University of Tabriz, 29th Bahman Blvd, Tabriz, 5166616471 Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, deep learning techniques have been widely used to diagnose diseases. However, in some tasks, such as the diagnosis of COVID-19 disease, due to insufficient data, the model is not properly trained and as a result, the generalizability of the model decreases. For example, if the model is trained on a CT scan dataset and tested on another CT scan dataset, it predicts near-random results. To address this, data from several different sources can be combined using transfer learning, taking into account the intrinsic and natural differences in existing datasets obtained with different medical imaging tools and approaches. In this paper, to improve the transfer learning technique and better generalizability between multiple data sources, we propose a multi-source adversarial transfer learning model, namely AMTLDC. In AMTLDC, representations are learned that are similar among the sources. In other words, extracted representations are general and not dependent on the particular dataset domain. We apply the AMTLDC to predict Covid-19 from medical images using a convolutional neural network. We show that accuracy can be improved using the AMTLDC framework, and surpass the results of current successful transfer learning approaches. In particular, we show that the AMTLDC works well when using different dataset domains, or when there is insufficient data.

Indexed as

Coronavirus pneumoniaCOVID-19 diagnosisDeep learningDiagnose diseasesMulti-source adversarial domain adaptation

Identifiers

PMID38625255
PMCPMC9838404

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.